Bell Biosystems Lands $2,058,230 Series A Financing Round

  • Feed Type
  • Date
    1/8/2014
  • Company Name
    Bell Biosystems
  • Mailing Address
    953 Indiana Street San Francisco, CA 94107
  • Company Description
    Bell Biosystems combines expertise in stem cell research, cell biology, oncology, biomedical imaging and molecular biology. Our vision is to create tools that accelerate the “bench-to-bedside” progress of innovations in oncology and cell therapy research.
  • Website
    http://www.bellbiosystems.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,058,230
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Includes conversion of convertible promissory notes. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy